Petra Diamonds’ Finsch rescue shows how the diamond slump is forcing miners to choose survival over scale
Read More Pharma Industry News Mirum Pharmaceuticals (NASDAQ: MIRM) jumps 13% after VISTAS Phase 2b PSC win Two Phase 2b wins in seven days. A pre-NDA meeting this summer. Mirum is starting to look less like a single-product rare disease story. bySrinathMay 5, 2026